Clinical Scoring Systems for Stratifying Risk after Resection of Hepatic Colorectal Metastases: Still Relevant?

被引：6

作者：

Jarnagin, William R. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA

来源：

ANNALS OF SURGICAL ONCOLOGY | 2011年 / 18卷 / 10期

关键词：

LIVER METASTASES; SURVIVAL; CANCER; CHEMOTHERAPY; PROPOSAL; MODEL;

D O I：

10.1245/s10434-011-1821-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：2711 / 2713

页数：3

共 15 条

[1]

Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16

[2]

Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy? [J].

Ayez, Ninos ;

Lalmahomed, Zarina S. ;

van der Pool, Anne E. M. ;

Vergouwe, Yvonne ;

van Montfort, Kees ;

de Jonge, Jeroen ;

Eggermont, Alexander M. M. ;

IJzermans, Jan N. M. ;

Verhoef, Cornelis .

ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (10) :2757-2763

[3]

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases [J].

Blazer, Dan G., III ;

Kishi, Yoji ;

Maru, Dipen M. ;

Kopetz, Scott ;

Chun, Yun Shin ;

Overman, Michael J. ;

Fogelman, David ;

Eng, Cathy ;

Chang, David Z. ;

Wang, Huamin ;

Zorzi, Daria ;

Ribero, Dario ;

Ellis, Lee M. ;

Glover, Katrina Y. ;

Wolff, Robert A. ;

Curley, Steven A. ;

Abdalla, Eddie K. ;

Vauthey, Jean-Nicolas .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (33) :5344-5351

[4]

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial [J].

Folprecht, Gunnar ;

Gruenberger, Thomas ;

Bechstein, Wolf O. ;

Raab, Hans-Rudolf ;

Lordick, Florian ;

Hartmann, Joerg T. ;

Lang, Hauke ;

Frilling, Andrea ;

Stoehlmacher, Jan ;

Weitz, Juergen ;

Konopke, Ralf ;

Stroszczynski, Christian ;

Liersch, Torsten ;

Ockert, Detlev ;

Herrmann, Thomas ;

Goekkurt, Eray ;

Parisi, Fabio ;

Koehne, Claus-Henning .

LANCET ONCOLOGY, 2010, 11 (01) :38-47

[5]

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases [J].

Fong, Y ;

Fortner, J ;

Sun, RL ;

Brennan, MF ;

Blumgart, LH .

ANNALS OF SURGERY, 1999, 230 (03) :309-318

[6]

Hepatic resection for metastatic colorectal adenocarcinoma: A proposal of a prognostic scoring system [J].

Iwatsuki, S ;

Dvorchik, I ;

Madariaga, JR ;

Marsh, JW ;

Dodson, F ;

Bonham, AC ;

Geller, DA ;

Gayowski, TJ ;

Fung, JJ ;

Starzl, TE .

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1999, 189 (03) :291-299

[7]

Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization [J].

Kao, Kuo-Jang ;

Chang, Kai-Ming ;

Hsu, Hui-Chi ;

Huang, Andrew T. .

BMC CANCER, 2011, 11

[8]

Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases [J].

Konopke, Ralf ;

Kersting, Stephan ;

Distler, Marius ;

Dietrich, Jeannine ;

Gastmeier, Jorg ;

Heller, Axel ;

Kulisch, Eberhard ;

Saeger, Hans-Detlev .

LIVER INTERNATIONAL, 2009, 29 (01) :89-102

[9]

A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection [J].

Nagashima, I ;

Takada, T ;

Matsuda, K ;

Adachi, M ;

Nagawa, H ;

Muto, T ;

Okinaga, K .

JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2004, 11 (02) :79-83

[10]

Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.3.CO

← 1 2 →